Data from the AVROBIO Phase 1/2 investigational gene therapy for cystinosis was released today at WORLDSymposium in San Diego....
read moreAVROBIO is looking for perspectives from the cystinosis community. They will be conducting a small focus group to help...
read morePartnering with RDMD, this program aims to accelerate cystinosis research to ultimately improve treatment options. We welcome you to...
read moreAVROBIO has released a brochure providing detail on investigational gene therapies for lysosomal storage disorders. Earlier this year, AVROBIO’s...
read moreAVROBIO has announced the first patient has been dosed in the company’s Phase 1/2 trial of AVR-RD-04, an investigational...
read more